| Literature DB >> 7606973 |
M Rubinger1, I H Plenderleith, M Lertzman, A J Worth.
Abstract
A patient with pulmonary metastatic extraskeletal myxoid chondrosarcoma (EMC), of unknown cause, responded dramatically to 16 months of therapy with interferon alfa-2b. This is the first report of a significant response of a patient with EMC to this novel treatment approach.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7606973 DOI: 10.1378/chest.108.1.281
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410